Haemonetics Corp. buy melinda
Start price
30.06.17
/
50%
€35.41
Target price
07.08.17
€38.34
Performance (%)
8.57%
End price
07.08.17
€38.45
Summary
This prediction ended on 07.08.17 with a price of €38.45. With a performance of 8.57%, the BUY prediction by melinda for Haemonetics Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Haemonetics Corp. | 0.000% | 0.000% | 15.753% | 55.046% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
Comments by melinda for this prediction
In the thread Haemonetics Corp. diskutieren
Antikoagulans Natriumcitrat 4% w / v-Lösung, USP Haemonetics Corp.
$
Stopped prediction by melinda for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
09.08.20
09.08.20
€75.00
04.11.21
04.11.21
-7.52%
05.11.21
05.11.21
Haemonetics Corp.
Start price
Target price
Perf. (%)
€29.23
07.11.13
07.11.13
€32.00
07.05.14
07.05.14
-24.01%
07.05.14
07.05.14